ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug BAT8010 tested in patients with advanced cancers
Disease control CompletedThis early-stage study tested a new drug called BAT8010 in 23 people with advanced or spreading solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the highest dose that can be given without causing severe side effects. Pa…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug, TAK-981, combined with the immunotherapy pembrolizumab in 161 adults with advanced or metastatic solid tumors that could not be cured. The main goals were to see if the combination was safe and to measure how well it shrank tumors. Participants recei…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New drug MRG004A targets tough cancers in early trial
Disease control CompletedThis early-phase study tested an experimental drug, MRG004A, in 39 adults with advanced or metastatic solid tumors that have a protein called tissue factor. The main goals were to find a safe dose and see if the drug can shrink tumors. Researchers also monitored side effects and …
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New drug WTX-330 tested in patients with advanced cancers
Disease control CompletedThis early-phase study tested a new drug called WTX-330 in 25 adults with advanced solid tumors or lymphoma that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study is now complete,…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC